1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Female Sexual Dysfunction Global Clinical Trials Review, H2, 2015

Female Sexual Dysfunction Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Female Sexual Dysfunction Global Clinical Trials Review, H2, 2015" provides an overview of Female Sexual Dysfunction clinical trials scenario. This report provides top line data relating to the clinical trials on Female Sexual Dysfunction. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Female Sexual Dysfunction Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Female Sexual Dysfunction to Women's Health Clinical Trials 15
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Female Sexual Dysfunction to Women's Health Clinical Trials 19
Clinical Trials by Phase in E7 Countries 21
Clinical Trials in E7 Countries by Trial Status 22
Clinical Trials by Phase 23
In Progress Trials by Phase 24
Clinical Trials by Trial Status 25
Clinical Trials by End Point Status 27
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Female Sexual Dysfunction Therapeutics Clinical Trials 32
Prominent Drugs 34
Latest Clinical Trials News on Female Sexual Dysfunction 35
Oct 28, 2015: Strategic Science and Technologies Initiates Phase 2 Study to Evaluate Topical Sildenafil in Women with Female Sexual Arousal Disorder 35
Clinical Trial Profile Snapshots 36
Appendix 146
Abbreviations 146
Definitions 146
Research Methodology 147
Secondary Research 147
About GlobalData 148
Contact Us 148
Disclaimer 148
Source 149

List of Tables
Female Sexual Dysfunction Therapeutics, Global, Clinical Trials by Region, 2015* 6
Female Sexual Dysfunction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Female Sexual Dysfunction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Female Sexual Dysfunction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Female Sexual Dysfunction Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Female Sexual Dysfunction Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Female Sexual Dysfunction Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13
Female Sexual Dysfunction Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Female Sexual Dysfunction to Women's Health Clinical Trials, G7 Countries (%), 2015* 16
Female Sexual Dysfunction Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 17
Female Sexual Dysfunction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 18
Proportion of Female Sexual Dysfunction to Women's Health Clinical Trials, E7 Countries (%), 2015* 20
Female Sexual Dysfunction Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 21
Female Sexual Dysfunction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 22
Female Sexual Dysfunction Therapeutics, Global, Clinical Trials by Phase, 2015* 23
Female Sexual Dysfunction Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 24
Female Sexual Dysfunction Therapeutics, Global, Clinical Trials by Trial Status, 2015* 26
Female Sexual Dysfunction Therapeutics Clinical Trials, Global, by End Point Status, 2015* 27
Female Sexual Dysfunction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Female Sexual Dysfunction Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 29
Female Sexual Dysfunction Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31
Female Sexual Dysfunction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 33
Female Sexual Dysfunction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 34

List of Figures
Female Sexual Dysfunction Therapeutics, Global, Clinical Trials by Region (%), 2015* 6
Female Sexual Dysfunction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Female Sexual Dysfunction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Female Sexual Dysfunction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Female Sexual Dysfunction Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Female Sexual Dysfunction Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Female Sexual Dysfunction Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13
Female Sexual Dysfunction Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Female Sexual Dysfunction to Women's Health Clinical Trials, G7 Countries (%), 2015* 15
Female Sexual Dysfunction Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 17
Female Sexual Dysfunction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 18
Proportion of Female Sexual Dysfunction to Women's Health Clinical Trials, E7 Countries (%), 2015* 19
Female Sexual Dysfunction Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 21
Female Sexual Dysfunction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 22
Female Sexual Dysfunction Therapeutics, Global, Clinical Trials by Phase (%), 2015* 23
Female Sexual Dysfunction Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 24
Female Sexual Dysfunction Therapeutics, Global, Clinical Trials by Trial Status, 2015* 25
Female Sexual Dysfunction Therapeutics Clinical Trials, Global, by End Point Status, 2015* 27
Female Sexual Dysfunction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 28
Female Sexual Dysfunction Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 29
Female Sexual Dysfunction Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 30
Female Sexual Dysfunction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32
Female Sexual Dysfunction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 34
GlobalData Methodology 147

Companies mentioned
Emotional Brain BV
Sprout Pharmaceuticals, Inc.
Pfizer Inc.
Allergan Plc
ANI Pharmaceuticals, Inc.
Vivus, Inc.
Strategic Sciences and Technologies, LLC
Palatin Technologies, Inc.
Acrux Limited
Apricus Biosciences, Inc.

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Erectile Dysfunction  - Market Insights, Epidemiology and Market Forecast-2023

Erectile Dysfunction  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Erectile Dysfunction - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and ...

Global Erectile Dysfunction Drugs Market Report 2016

Global Erectile Dysfunction Drugs Market Report 2016

  • $ 2850
  • Industry report
  • August 2016
  • by 9Dimen Research

2016 Global Erectile Dysfunction Drugs Report is a professional and in-depth research report on the world's major regional market conditions of the Erectile Dysfunction Drugs industry, focusing on the ...

Erectile Dysfunction  - Epidemiology Forecast To 2023

Erectile Dysfunction  - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight “Erectile Dysfunction  - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Erectile Dysfunction  in seven major markets (US, France, Germany, Italy, Spain, ...


Download Unlimited Documents from Trusted Public Sources

Opioid and Dysfunction Drug Market in Canada

  • October 2016
    71 pages
  • Opioid  

    Dysfunction Dru...  

  • Canada  

View report >

Dysfunction Drug Market and Genitourinary System Disease Statistics in the UK

  • August 2016
    15 pages
  • Dysfunction Dru...  

    Genitourinary S...  

    Dermatological ...  

  • United Kingdom  

View report >

Hormone and Therapy Market in the US

  • July 2016
    8 pages
  • Hormone  

    Therapy  

    Prostate Cancer  

  • United States  

View report >

Therapy Market In The Us

11 months ago

Therapy Market In Israel

11 months ago

Related Market Segments :

Dysfunction Drug
Dietary Supplement

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.